HHV8-Positive Multicentric Castleman Disease Not Yet Recruiting Phase 1 Trials for Etoposide (DB00773)

IndicationStatusPhase
DBCOND0118532 (HHV8-Positive Multicentric Castleman Disease)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03864419Rituximab Hyaluronidase and Combination Chemotherapy in Treating Aggressive B-cell Lymphoma in UgandaTreatment